North America Hip Reconstruction Devices Market, By Product (Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement, Hip Resurfacing), and By Region (U.S., Canada, Mexico) – Forecast to 2021
The total hip replacement is also referred to as total hip arthroplasty/hip resurfacing. It is a very common surgery that helps to minimize pain and rigidity in the hip joint. The total hip replacement is categorized into four segments, namely, primary hip reconstruction, partial hip reconstruction, hip resurfacing, and revision hip implants.
Primary hip reconstruction procedures are performed to replace the complete hip joint. It consists of three components: a femoral stem, a femoral head, and an acetabular cup. As with the stem, the acetabular cup can be cemented or cementless, which is most common due to its superiority. A partial hip reconstruction is performed when only femoral component of hip joints is to be replaced. This type of implant uses similar modular components to a total hip replacement, however, either a unipolar or bipolar head along with femoral stem is used for this type of surgery. A partial hip prosthesis is comparatively less expensive and consumes less time for implant than a total replacement.
North America hip reconstruction devices market is broadly classified on the basis of product and regions. Based on product, the market is broadly segmented into primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices and hip resurfacing devices. The primary hip reconstruction devices are sub segmented into cementless and cemented reconstruction device. The North American regions covered in this report are U.S., Canada and Mexico. The U.S. market in accounted the largest share in the North America hip reconstruction devices market in 2015.
The U.S. hip reconstruction devices market was valued USD 1.97 billion in 2015 and is expected to reach USD 2.44 billion by 2021, at a CAGR of 3.6% from 2016 to 2021.
In 2015, 410,883 hip reconstruction procedures were performed and the number is expected to reach 530,587 by 2021, at a CAGR of 5.1% from 2016 to 2021.
Rising pool of arthritis, favorable reimbursement, and technological advancements are the major factors responsible for the growth of hip reconstruction devices market. Additionally, growing health awareness among masses, along with increase in the spending capacity of the population are also propelling the market towards growth. However, price pressure, risk of complication after surgery, and waiting time for surgery in hospitals are major hindering factors.
The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, new product launch, M&A, and product approvals of the major companies would be detailed. Zimmer Inc. (U.S.), DePuy Synthes (U.S.), Stryker (U.K.), and Smith & Nephew (U.K.), are some of the key players operating in this market.
These companies have adopted various strategies, such as merger & acquisition and partnership, among others, to achieve growth in the North America hip reconstruction devices market.
STAKEHOLDERS
- Orthopedic Implants Manufacturing Companies
- Medical Device Distributors
- Healthcare Institutions (Hospitals, Medical Schools, and Governing Bodies)
- Health Insurance Players
- Research and Consulting Firms
- Regulatory Authorities, such as Food and Drug Administration (FDA)
Scope of the Report:
This report categorizes the global market for hip reconstruction devices on the basis of product, and region.
Market Segmentation, by Product:
- Primary hip reconstruction devices
- Partial hip reconstruction devices
- Revision hip reconstruction devices
- Hip resurfacing devices
Market Segmentation, by region:
- North America
- U.S.
- Canada
- Mexico
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Asia Hip Replacement Devices The report “Asian Hip Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Hip Replacement Devices and Hip Resurfacing Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of hip osteoarthritis and rheumatoid arthritis.The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in The Asian Hip Replacement Devices Market are extensively covered in this report are Stryker, Zimmer, DePuy Synthes, Medtronic, Smith and Nephew, Exactech Inc., Tornier, Biomet Inc., Wright Medical Group and Ottobock. |
Upcoming | |
North America Hip Replacement Devices The report “North American Hip Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Hip Replacement Devices and Hip Resurfacing Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of hip osteoarthritis and rheumatoid arthritis.The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in The North American Hip Replacement Devices Market are extensively covered in this report are Stryker, Zimmer, DePuy Synthes, Medtronic, Smith and Nephew, Exactech Inc., Tornier, Biomet Inc., Wright Medical Group and Ottobock. |
Upcoming | |
Europe Hip Replacement Devices The report “European Hip Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Hip Replacement Devices and Hip Resurfacing Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of hip osteoarthritis and rheumatoid arthritis. |
Upcoming |